House approves insurance coverage of FDA‑approved nonprescription hormonal contraceptives

The House passed a bill requiring health insurance coverage for federally approved nonprescription oral hormonal contraceptives and nonprescription emergency contraceptives, with proponents arguing it removes financial barriers for people who otherwise lack easy access to prescription contraceptives.

Supporters said the bill provides "first‑dollar" coverage so insured people can pick up FDA‑approved products at the pharmacy without co‑pays or prior prescriptions. A floor sponsor emphasized access for younger and lower‑income Mainers who may face barriers to obtaining prescriptions from clinicians and said the policy expands options while maintaining insurer regulation.

Opponents warned the measure would set a precedent requiring insurers to cover over‑the‑counter medicines generally. Representative Foley noted insurers would have to process claims outside standard pharmacy reimbursement channels, raising administrative burdens and potential fraud risks if purchases are not tied to a named insured. Representative Folkingham asked during debate whether the bill capped purchases per month; the chair's answer on the floor was that no per‑month limit appears in the bill.

The House approved the committee motion on the bill in a roll call reported as 73 affirmative and 69 negative; the measure was advanced to the Senate for further consideration.

Speakers stressed the bill is distinct from access to the products themselves (which some speakers noted are already available over the counter) and instead focuses on whether insurers regulated by the state must reimburse such purchases.